Advancing Bioluminescence Imaging Technology for the Evaluation of Anticancer Agents in the MDA-MB-435-HAL-Luc Mammary Fat Pad and Subrenal Capsule Tumor Models

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Cancer Research

• Publication date

  2009-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-08-0897PMID 19118051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer

  2010cited by this paper
• Advances in optical imaging and novel model systems for cancer metastasis research

  2007cited by this paper
• Monitoring of tumor growth and metastasis potential in MDA-MB-435s/tk-luc human breast cancer xenografts

  2007cited by this paper
• Cancer: To grow and spread

  2007cited by this paper
• On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing

  2007cited by this paper
• Whole-Body Optical Imaging in Animal Models to Assess Cancer Development and Progression

  2007cited by this paper
• An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.

  2007cited by this paper
• Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging.

  2007cited by this paper
• Models for spontaneous metastasis.

  2006cited by this paper
• Fluorescence molecular imaging.

  2006cited by this paper
• The multiple uses of fluorescent proteins to visualize cancer in vivo

  2005cited by this paper
• Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model.

  2005cited by this paper
• Tomographic fluorescence mapping of tumor targets.

  2005cited by this paper
• Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells

  2005cited by this paper
• Mouse Colon Carcinoma Cells Established for High Incidence of Experimental Hepatic Metastasis Exhibit Accelerated and Anchorage-Independent Growth

  2005cited by this paper
• Optical imaging in drug discovery and diagnostic applications.

  2005cited by this paper
• Unraveling the Complexity of Oncogenesis Through In Vivo Optical Imaging

  2005cited by this paper
• Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors

  2004influential reference
• SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model

  2004cited by this paper
• Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice.

  2004cited by this paper
• Lineage Infidelity of MDA-MB-435 Cells

  2004cited by this paper
• MRI monitoring of Avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer

  2004cited by this paper
• Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden.

  2004cited by this paper
• Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry

  2004cited by this paper
• Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice.

  2004cited by this paper
• Orthotopic Metastatic Mouse Models for Anticancer Drug Discovery and Evaluation: a Bridge to the Clinic

  2004cited by this paper
• Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.

  2004cited by this paper
• Quantitative Comparison of the Sensitivity of Detection of Fluorescent and Bioluminescent Reporters in Animal Models

  2004cited by this paper
• Modeling metastasis in vivo.

  2004cited by this paper
• The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

  2003cited by this paper
• Cell uptake and tissue distribution of radioiodine labelled D-luciferin: implications for luciferase based gene imaging

  2003cited by this paper
• Advancing animal models of neoplasia through in vivo bioluminescence imaging.

  2002cited by this paper
• Systematic variation in gene expression patterns in human cancer cell lines

  2000cited by this paper
• Cadmium-induced inhibition of the growth and metastasis of human lung carcinoma xenografts: role of apoptosis.

  1999cited by this paper
• In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.

  1999cited by this paper
• Technical considerations for studying cancer metastasis in vivo

  1997cited by this paper
• Chemosensitivity of human melanoma metastases in mouse subrenal capsule assay—can it predict tumour response to combined cytostatic plus interferon therapy in metastatic melanoma?

  1996cited by this paper
• Preclinical pharmacology of docetaxel.

  1995cited by this paper
• Studies of human breast cancer metastasis using nude mice

  1990cited by this paper
• The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatment.

  1985cited by this paper
• Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice.

  1985cited by this paper
• The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 years of experience.

  1984cited by this paper
• Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: Six‐day subrenal capsule assay

  1981cited by this paper
• Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro.

  1980cited by this paper
• Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization

  1978cited by this paper

• Photoacoustic imaging for investigating tumor hypoxia: a strategic assessment

  2023cites this paper
• Carbon Dots as a Potential Therapeutic Agent for the Treatment of Cancer‐Related Anemia

  2022cites this paper
• Advances in Rodent Models for Breast Cancer Formation, Progression, and Therapeutic Testing

  2021cites this paper
• The role of in vivo imaging in drug discovery and development

  2021cites this paper
• Potential Limitations of Bioluminescent Xenograft Mouse Models: A Systematic Review.

  2020cites this paper
• A new approach for cancer treatment: from specific induction of breast cancer to innovative gold-nanoparticle mediated thermal therapies

  2020cites this paper
• Theranostic Nanoprobes Mediated Simultaneous Monitoring and Inhibition of P-glycoprotein Potentiates Multidrug-Resistant Cancer Therapy.

  2019cites this paper
• PEGylated hollow gold nanoparticles for combined X-ray radiation and photothermal therapy in vitro and enhanced CT imaging in vivo.

  2019cites this paper
• The Role of In Vivo Imaging in Drug Discovery and Development

  2019cites this paper
• Accurate cancer cell identification and microRNA silencing induced therapy using tailored DNA tetrahedron nanostructures† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc04823e

  2019cites this paper
• Mouse models of breast cancer in preclinical research

  2018cites this paper
• Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms

  2017cites this paper
• CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer.

  2017cites this paper
• 1 CD 155 T / TIGIT Signaling Regulates CD 8 + T Cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer

  2017cites this paper
• Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia

  2017cites this paper
• Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.

  2016cites this paper
• Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway

  2015cites this paper
• Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer

  2015cites this paper
• New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

  2014cites this paper
• Evaluation of Novel Multi-Dimensional Tissue Culturing Methods Using Autonomously Bioluminescent Human Cell Lines

  2014cites this paper
• Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy.

  2013cites this paper
• Cancer Cell Migration and Bone Metastases Orai1 Complex in Human - Pivotal Role of the Lipid Raft SK3

  2013cites this paper
• The Influence of Hypoxia and pH on Bioluminescence Imaging of Luciferase-Transfected Tumor Cells and Xenografts

  2013cites this paper
• Synergistic Effect of the γ‐Secretase Inhibitor PF‐03084014 and Docetaxel in Breast Cancer Models

  2013cites this paper
• Trimethoxy‐Resveratrol and Piceatannol Administered Orally Suppress and Inhibit Tumor Formation and Growth in Prostate Cancer Xenografts

  2013cites this paper
• Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases.

  2013cites this paper
• Targeting cell cycle and hormone receptor pathways in cancer

  2013cites this paper
• Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancer.

  2012cites this paper
• Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease.

  2012cites this paper
• Cyclin D1-AR Crosstalk: Potential Implications for Therapeutic Response in Prostate Cancer

  2012cites this paper
• All-optical quantitative framework for bioluminescence tomography with non-contact measurement

  2012cites this paper
• Generation and characterization of orthotopic murine models for endometrial cancer

  2011cites this paper
• MRI of metastasis-permissive microenvironments.

  2011cites this paper
• The 'Gator' Mouse Suit for early bioluminescent metastatic breast cancer detection and nanomaterial signal enhancement during live animal imaging.

  2011cites this paper
• Imaging Efficacy in Tumor Models

  2011cites this paper
• Molecular Imaging of Cancer and the Implications for Pre-invasive Disease

  2011cites this paper
• Models for Evaluation of Targeted Therapies of Invasive and Metastatic Disease

  2011cites this paper
• Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells

  2011cites this paper
• PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity

  2010cites this paper
• Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts.

  2010cites this paper
• In Vivo Bioluminescent Imaging (BLI): Noninvasive Visualization and Interrogation of Biological Processes in Living Animals

  2010cites this paper
• Applications of molecular MRI and optical imaging in cancer.

  2010cites this paper
• 2 Murine L 1210 and P 388 Leukemias

  2010cites this paper
• PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts

  2009cites this paper
• Contemporary pre-clinical development of anticancer agents--what are the optimal preclinical models?

  2009cites this paper